menu
    • menu

    Company profile for EpiVax

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    EpiVax is a privately-held biotechnology company based in Providence, RI that is dedicated to the development and implementation of computational immunology tools to benefit the biotechnology industry. EpiVax intends to utilize its scientific and technological assets related to epitope discovery, de-immunization, and vaccine design through a mix of collaborative and internal programs by applying the following business strat...
    EpiVax is a privately-held biotechnology company based in Providence, RI that is dedicated to the development and implementation of computational immunology tools to benefit the biotechnology industry. EpiVax intends to utilize its scientific and technological assets related to epitope discovery, de-immunization, and vaccine design through a mix of collaborative and internal programs by applying the following business strategies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    EpiVaxUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    188 Valley Street, Suite 424 Providence, RI 02909,
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://epivax.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/epivax-inc-/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/EpiVax_BD

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    EpiVax Appoints Dr. Vibha Jawa to Lead Scientific Strategy as CSO
    EpiVax Appoints Dr. Vibha Jawa to Lead Scientific Strategy as CSO

    28 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/epivax-appoints-dr-vibha-jawa-to-lead-scientific-strategy-as-cso-302466547.html

    PR NEWSWIRE
    28 May 2025
    Share Share
    Tregitopes' Role in Antibody Maturation Revealed in EpiVax Study
    Tregitopes' Role in Antibody Maturation Revealed in EpiVax Study

    21 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/the-role-of-treg-epitopes-tregitopes-in-antibody-maturation-uncovered-in-new-epivax-study-implications-for-therapeutic-antibodies-302432863.html

    PR NEWSWIRE
    21 Apr 2025
    Share Share
    EpiVax Drives Immunogenicity Innovation in 2024: Year in Review
    EpiVax Drives Immunogenicity Innovation in 2024: Year in Review

    06 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/epivax-drives-immunogenicity-innovation-in-2024-year-in-review-302325387.html

    PR NEWSWIRE
    06 Dec 2024
    Share Share
    EpiVax And CUBRC Awarded $2M FDA Contract For Control Peptides
    EpiVax And CUBRC Awarded $2M FDA Contract For Control Peptides

    24 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/epivax-y-cubrc-obtienen-contrato-con-la-fda-para-el-desarrollo-de-peptidos-de-control-302286121.html

    PR NEWSWIRE
    24 Oct 2024
    Share Share
    EpiVax Licenses ISPRI Toolkit to Eisai for silico Immunogenicity Screening
    EpiVax Licenses ISPRI Toolkit to Eisai for silico Immunogenicity Screening

    20 Dec 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/epivax-licenses-ispri-toolkit-to-eisai-for-preclinical-in-silico-immunogenicity-screening-302020194.html

    PR NEWSWIRE
    20 Dec 2023
    Share Share
    EpiVax and Zoetis to Collaborate on Swine T cell Epitope Prediction Tool
    EpiVax and Zoetis to Collaborate on Swine T cell Epitope Prediction Tool

    10 Jan 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/epivax-and-zoetis-to-collaborate-on-swine-t-cell-epitope-prediction-tool-circomatch-301715606.html

    PR NEWSWIRE
    10 Jan 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search